Why there is great need for additional treatments to manage hyperphosphatemia in patients with CKD on dialysis October 5, 2021 Auto Bot BioPharma, biopharma nl, chronic kidney disease, MedCity Influencers, News 0 Given the suboptimal outcomes with existing therapies to manage chronic kidney disease patients on dialysis, there is a substantial unmet need that additional treatment options could potentially address.